Dr. Alice Wang-Chesebro, MD
- Medicare services, 2024
- 438
- Medicare patients, 2024
- 92
- Part D claims, 2024
- 46
- Clinical trials
- 6
- Hospital affiliations
- 4
- Practice address
- 9280 SE Sunnybrook Blvd, Clackamas, OR 97015
- Practice phone
- Call (503) 215-1837
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Clackamas Radiation Oncology Center
Clackamas, Oregon
Find Dr. Wang-Chesebro's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alice Wang-Chesebro is a radiation oncologist in Clackamas, Oregon
Dr. Wang-Chesebro practices at Clackamas Radiation Oncology Center in Clackamas, Oregon.
Dr. Wang-Chesebro's NPI, 1558532507, was assigned on March 18, 2008. Dr. Wang-Chesebro graduated from Johns Hopkins University School of Medicine in 2003. Dr. Wang-Chesebro holds Oregon license MD28340.
- NPI
- 1558532507NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2668545328
- NPI enumeration date
- March 18, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (503) 215-1837
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Alice Wang-Chesebro practices at Clackamas Radiation Oncology Center in Clackamas, Oregon
Dr. Wang-Chesebro's primary practice is Clackamas Radiation Oncology Center, at 9280 SE Sunnybrook Blvd, Clackamas, OR 97015 in Clackamas County. The practice phone is (503) 215-1837.
- Clackamas Radiation Oncology Center9280 SE Sunnybrook Blvd, Clackamas, OR 97015 · Clackamas CountyPhone(503) 215-1837
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Alice Wang-Chesebro is affiliated with 5 sites of care and 1 medical group
Dr. Wang-Chesebro's primary practice is Clackamas Radiation Oncology Center in Clackamas, Oregon. Dr. Wang-Chesebro is also affiliated with OHSU Hospital. The medical group on file is The Oregon Clinic. Dmand AI also links Dr. Wang-Chesebro to 3 more hospitals, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alice Wang-Chesebro's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang-Chesebro practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Clackamas Radiation Oncology Center | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alice Wang-Chesebro is one of 98 radiation oncologists in Oregon
Radiation oncology is Dr. Wang-Chesebro's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Wang-Chesebro is licensed in Oregon.
Specialties and state licenses
- Radiation oncology, OregonPrimary
Radiation oncologists near Dr. Wang-Chesebro
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alice Wang-Chesebro billed Medicare for 438 services in 2024
CMS data shows 438 Medicare services from Dr. Wang-Chesebro across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $21,143 for them.
Dr. Wang-Chesebro's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 4032024: 4122%
- Office and hospital visits
- 2023: 312024: 2616%
Where Dr. Wang-Chesebro's Medicare services took place, 2024
- In an office12328%
- In a facility31572%
Dr. Wang-Chesebro compared with the Oregon median for radiation oncologists, 2024
- Dr. Wang-Chesebro
- Oregon median
- Medicare services
- 438vs 83948% below
- Medicare patients
- 92vs 14034% below
- Part D claims
- 12vs 4774% below
Medians across 99 radiation oncologists in Oregon with Dmand AI profiles that report each measure.
Dr. Wang-Chesebro's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wang-Chesebro?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wang-Chesebro and other radiation oncologists in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alice Wang-Chesebro treated 92 Medicare patients in 2024, average age 73
CMS counts 92 Medicare patients who saw Dr. Wang-Chesebro in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have cancer, and 65% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Wang-Chesebro's median patient age at 72, with 66% women.
Dr. Wang-Chesebro's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Wang-Chesebro's Medicare patients by sex, 2024
- Women5964%
- Men3336%
Chronic conditions among Dr. Wang-Chesebro's Medicare patients, 2024
- Cancer75%
- High blood pressure65%
- High cholesterol60%
- Arthritis32%
- Mood disorders30%
- Depression29%
- Anxiety26%
- Diabetes24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Wang-Chesebro's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women66%
- Men34%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alice Wang-Chesebro wrote 46 Medicare Part D claims in 2024
In 2024, Dr. Wang-Chesebro wrote 46 Medicare Part D claims for 31 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $383 in total drug cost.
Dr. Wang-Chesebro's Part D claims by kind of drug, 2024
- Generic41 claims89%
- Brand-name and other5 claims11%
Dr. Wang-Chesebro's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alice Wang-Chesebro offers telehealth to Medicare patients
Dr. Wang-Chesebro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang-Chesebro as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alice Wang-Chesebro has worked on 6 clinical trials
Dmand AI links Dr. Wang-Chesebro to 6 clinical trials, 3 of them phase 2 studies. 4 are still active or recruiting. Conditions studied include Carcinoma, Renal Cell, Glioblastoma and Melanoma. Providence Health & Services sponsors the most, 6.
Clinical trials with Dr. Wang-Chesebro by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 3Phase 2: 3 trials
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Wang-Chesebro's trials
- Carcinoma, Renal Cell
- Glioblastoma
- Melanoma
- Neoplasm Metastasis
- Rectal Neoplasms
Investigators on the most trials with Dr. Wang-Chesebro
- Matthew Curtis Solhjem, MD6 shared trials
- Marka Rae Crittenden, MD, PhD5 shared trials
- Steven Kysung Seung, MD, PhD5 shared trials
Recent clinical trials with Dr. Wang-Chesebro
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma (opens in a new tab)
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer (opens in a new tab)
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (opens in a new tab)
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alice Wang-Chesebro received $382 in industry payments from 2016 to 2025
CMS Open Payments shows 8 general payments to Dr. Wang-Chesebro from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $148.
General payments to Dr. Wang-Chesebro by program year, 2016 to 2025
Companies that paid Dr. Wang-Chesebro the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alice Wang-Chesebro graduated from Johns Hopkins University School of Medicine
Dr. Wang-Chesebro graduated from Johns Hopkins University School of Medicine in 2003.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Alice Wang-Chesebro's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alice Wang-Chesebro
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alice Wang-Chesebro's NPI number?
Dr. Alice Wang-Chesebro's NPI number is 1558532507. It was assigned on March 18, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Alice Wang-Chesebro?
Dr. Alice Wang-Chesebro is a radiation oncologist in Clackamas, Oregon. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Alice Wang-Chesebro practice?
Dr. Wang-Chesebro practices at 9280 SE Sunnybrook Blvd, Clackamas, OR 97015. Dr. Wang-Chesebro's primary practice is Clackamas Radiation Oncology Center in Clackamas, Oregon. Dmand AI also links Dr. Wang-Chesebro to 3 hospitals.
What is Dr. Alice Wang-Chesebro's office phone number?
The practice phone on file for Dr. Wang-Chesebro is (503) 215-1837.
What is Dr. Alice Wang-Chesebro's medical license number?
Dr. Wang-Chesebro holds Oregon license MD28340.
Which hospitals is Dr. Alice Wang-Chesebro affiliated with?
Dr. Wang-Chesebro is affiliated with OHSU Hospital. Dmand AI links Dr. Wang-Chesebro to 3 more hospitals.
What medical group is Dr. Alice Wang-Chesebro part of?
Dr. Wang-Chesebro is linked to The Oregon Clinic.
Does Dr. Alice Wang-Chesebro accept Medicare?
Yes. CMS data shows Dr. Wang-Chesebro billed Medicare for 438 services in 2024, and Dr. Wang-Chesebro accepts Medicare assignment.
Does Dr. Alice Wang-Chesebro offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Wang-Chesebro as offering telehealth services.
How many Medicare patients does Dr. Alice Wang-Chesebro see?
CMS counts 92 Medicare patients who saw Dr. Wang-Chesebro in 2024, with an average age of 73.
Show 6 more questionsShow fewer questions
What services does Dr. Alice Wang-Chesebro bill to Medicare?
In 2024, Dr. Wang-Chesebro's most billed Medicare services were radiation oncology (77014), radiation oncology (77334) and radiation oncology (77300).
Where did Dr. Alice Wang-Chesebro go to medical school?
Dr. Wang-Chesebro graduated from Johns Hopkins University School of Medicine in 2003.
What drugs does Dr. Alice Wang-Chesebro prescribe most?
In 2017 Medicare Part D data, Dr. Wang-Chesebro's most prescribed drugs by claims were Ssd.
Has Dr. Alice Wang-Chesebro received payments from drug or device companies?
CMS Open Payments shows $382 in general payments to Dr. Wang-Chesebro from 6 companies from 2016 to 2025. The largest total came from Elekta, Inc.
How long has Dr. Alice Wang-Chesebro been practicing?
Dr. Wang-Chesebro graduated from medical school in 2003, 23 years ago.
Does Dr. Alice Wang-Chesebro do research?
Dr. Wang-Chesebro has worked on 6 clinical trials.
Selling to radiation oncology practices?
See radiation oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card